Thursday, October 26th, 2017 at 2PM EST
This unique webinar highlights key findings from a recent educational series to train counselors, clinicians, and other healthcare providers working in substance use disorder clinics to provide sustainable education to their patients on HCV risks, testing, and harm reduction. Expert faculty will share practical insights and results for increasing HCV awareness and knowledge among persons with substance use disorders, and strategies for strengthening testing and linkage to care.
1.0 hour of ACCME, APA, ACPE, ANCC, and CCMC credit for Psychologists, Physicians, NPs, PAs, Nurses, and Case Managers.
I. Understanding Barriers to HCV Linkage to Care
II. Key Findings from an HCV Educational Initiative in Substance Use Disorder Clinics
III. Evidence-Based Strategies for Promoting HCV Screening and Testing
IV. Evidence-Based Strategies for Harm Reduction
• Evaluate patients with, or at risk of, HCV infection in order to make appropriate referrals
to specialists for screening, diagnosis, treatment, or follow-up
• Apply evidence-based strategies for supporting persons with injection drug use in harm reduction and adhering to potential HCV treatment and monitoring regimens
• Summarize key efficacy/safety data on new and emerging direct-acting antiviral therapies
• Integrate patient-centered HCV education into substance use/addiction center visits